Category Archives: Medicine Wellness Health

Medicine Wellness Health

From Vision to reality

Functional diagnostic of small vessels can prevent perfusion damages

From Vision to reality

Retinal Vessel Analysis

In every organ a system of very small blood vessels (the so-called microcirculation) is doing an important job to keep us healthy. The changing blood supply and the exchange of metabolites and oxygen according to varying demands in different tissue areas is organized by complex regulatories in the vessel diameters. If the work of the microcirculation is impaired, vessel diseases arise including well-known harm for our health.
Imedos Systems GmbH has investigated and developed a trendsetting and worldwide unique technology, the Dynamic Vessel Analysis, together with physicians and researchers of the Institute of Biomedical Engineering and Informatics of the Technical University of Ilmenau. „This technology uses light to look inside the eye at the blood vessels of the retinal microcirculation. By applying flickering light we can investigate the vessel function and their regulation based on the vessel diameter changes. So we can observe the smallest vessels of man live at work.“ Dr.-Ing. W. Vilser, CEO of Imedos Systems GmbH explains. „With the previous examination techniques the ophthalmologist can usually detect damages. Our technology, however, is capable of detecting functional disorders leading to vessel diseases long before damages are present.“ This is creating a unique prerequisite for on time and controlled prevention of vascular diseases of the retina, e.g. glaucoma.
Studies also show that the function of retinal vessels reflect general vessel changes of the microcirculation which can be found in other organs, e.g. brain and heart. These parts of the microcirculation are not easily accessible. They can be examined via the eye, though. This is providing a wide range of application of the Imedos technology for the entire vascular medicine far beyond ophthalmology.

The microcirculation of the retina is an excellent window to the heart and the brain. Retinal vessels offer the unique opportunity to be examined in vivo and non-invasively and to provide valuable information about the condition of the body“s microcirculation. Imedos uses those characteristics of the ocular transparency to analyse retinal arteries and veins. Backed by several decades of research and development work, Imedos has become an established supplier of analytical systems for retinal vessels.

Company-Contact
Imedos Systems GmbH
Benedikt Krauß
Am Nasstal 4
07751 Jena
Phone: 03641639624
E-Mail: b.krauss@imedos.de
Url: http://www.imedos.de

Press
Imedos Systems GmbH
Annekathrin Härter
Am Nasstal 4
07751 Jena
Phone: 03641986953
E-Mail: a.haerter@imedos.de
Url: http://www.imedos.de

Medicine Wellness Health

TAITRA Presents Top Products at MEDICA 2018

TAITRA Presents Top Products at MEDICA 2018

The Taiwan External Trade Development Council (TAITRA) promotes the sale of Taiwanese products at home and abroad. At today’s MEDICA press conference, TAITRA focused on particularly innovative products from the fields of medical technology and e-health.

Düsseldorf, 13 November 2018
Five Taiwanese exhibitors took the opportunity to present their latest product innovations to international trade journalists. At the invitation of TAITRA, representatives from HTC, Taiwan Main Orthopedics, AmCad BioMed, BAUI Biotech and Rehabotics Medical Technology stood before an engaged audience and presented insights into the ambitious research and development work in Taiwan as well as their latest product innovations.

For example, the HTC Group relies heavily on virtual reality and impresses in two respects with the VR glasses VIVE. First, VIVE provides access to the first anatomical 3D atlas. On the other hand, the glasses have already achieved initial successes in the therapy of the fear of heights. Absolutely innovative is the fact that the therapy is accompanied by a virtual trainer instead of a human therapist.

The Virtual Dissection Table and the surgical glasses from Taiwan Main Orthopedics are also highly technical. The treatment table, which displays fully anatomical structures and, is suitable both for teaching purposes and for planning surgical interventions. The intelligent surgical spectacles complement the range and enable doctors to partially look into the patient’s body during a minimally invasive procedure and to display a 3D model of nerves and vessels.

AmCad BioMed Corporation is countering obstructive sleep apnea syndrome with a promising new diagnostic device. The AmCAD-UO consists of a positioning system and computer-aided recognition software. After only ten minutes, the AmCAD-UO provides accurate results and thus ensures efficiency and flexibility in treatment.

After two years of research and development, BAUI Biotech launches the NOVA Minimally Invasive System, which can be used to optimize surgical procedures on the spine. Both the patient and the surgeon benefit from the versatile small screw. The NOVA system effectively stabilizes the spinal column using polyaxial screws with long, fragile blades.

Rehabotics Medical Technology Corporation presents an innovative robotics product. The Mirror Hand was developed to support and accelerate the rehabilitation of the hands, for example after strokes, and to provide patients with practical help in coping with their everyday lives. Weighing only 750 grams, it is by far one of the lightest robotic rehabilitation devices for the hand.

Taiwan relies on technological progress
For many years, Taiwan has enjoyed an excellent reputation as a location for the manufacture of high-quality consumer electronics and medical technology equipment, which the small country has now been able to develop into a significant competitive advantage. TAITRA is committed to those companies that are entering the market with particularly innovative ideas and acts as a partner, mediator and consultant when it comes to initiating and concluding transactions between Taiwanese companies and customers at home and abroad. At the TAITRA joint exhibition stand at the current MEDICA, 15 companies present their new products, which have received the „Taiwan Excellence Award“.

About TAITRA:
TAITRA was founded in 1970 as a non-profit trade promotion organization. Supported by the Taiwanese government, TAITRA opens up new national and international sales markets for member companies from various sectors. TAITRA has created the „Taiwan Excellence“ label, which is awarded every year to particularly innovative products or companies. TAITRA is headquartered in Taiwan’s capital Taipei. The organization has a total of 61 branches worldwide. In Germany, TAITRA has two offices in Düsseldorf and Munich.

Founded in 1970 to help promote foreign trade, the Taiwan External Trade Development Council (TAITRA) is the foremost non-profit trade promotion organization in Taiwan. Jointly sponsored by the government, industry associations, and several commercial organizations, TAITRA assists Taiwan businesses and manufacturers with reinforcing their international competitiveness and in coping with the challenges they face in foreign markets.

TAITRA boasts a well-coordinated trade promotion and information network of over 1,300 trained specialists stationed throughout its Taipei headquarters, four local branch offices in Hsinchu, Taichung, Tainan and Kaohsiung, and 60 overseas branch offices worldwide. Together with its sister organizations, Taiwan Trade Center (TTC) and Taipei World Trade Center (TWTC), TAITRA has created a wealth of trade opportunities through effective promotion strategies.

Company-Contact
Taiwan External Trade Development Council
Frances Lin
Immermannstr. 33
40210 Dusseldorf
Phone: +49 (0)228 / 919 37 -66
E-Mail: taiwanexcellence@agentur-drilling.de
Url: https://www.taiwanexcellence2018.de/pk/

Press
DRILLING GmbH
Ben Giese
CelsiusStr. 43
53125 Bonn
Phone: +49 (0)228 / 919 37 -66
E-Mail: taiwanexcellence@agentur-drilling.de
Url: https://www.taiwanexcellence2018.de/pc/

Medicine Wellness Health

biolitec® at Medica 2018: 10 years ELVeS® Radial® laser therapy and excellent healing successes in proctology and urology with LEONARDO® lasers

10 years ELVeS® Radial® procedure – Studies prove excellent healing rates of biolitec procedures for coccyx fistulas and BPH – New laser fiber „Sharp tip“ specially developed for microsurgical procedures – biolitec® at Medica Hall 10 Stand H46

biolitec® at Medica 2018: 10 years ELVeS® Radial® laser therapy and excellent healing successes in proctology and urology with LEONARDO® lasers

(Source: biolitec®)

Jena, November 09, 2018 – The laser pioneer biolitec® set standards when it developed the ELVeS® Radial® method for the minimally invasive endovenous treatment of varicose veins and launched it on the market in 2008. The next revolution followed in 2012 with the ELVeS® Radial® 2-ring fiber, which was expanded to include two light rings that divide the laser power into two equal parts of 50% each and thus produce even more homogeneous radiation. The side effects can be reduced even further with a very high occlusion rate, further minimizing postoperative pain and ecchymosis. Since 2017, the ELVeS® Radial® 2ring slim fiber with a diameter of only 1.3 mm has been available and thus offers the possibility of treating perforating veins and side branches as well as more complicated anatomical structures and stripping relapses in addition to the larger trunk veins.

With the biolitec® therapies FiLaC® (Fistula-tract Laser Closure for anal fistulae), SiLaC® (Sinus Pilonidalis treatment) and LHP® (LaserHemorrhoidoPlasty for hemorrhoids) for proctology, biolitec® has developed innovative minimally invasive methods in which the tissue is irradiated from the inside with the laser energy and thus gently destroyed. The treatment of coccyx fistulas can achieve a cure rate of over 90% after the first treatment with the new, particularly gentle minimally invasive method SiLaC® from biolitec®. This was the result of a study carried out on 237 patients at the gastroenterological department of the University Hospital Ioannina, Greece, and published in June 2018.

About one third of all women over 30 years of age are affected by myomas. The gentle and, above all, uterus-preserving treatment of myomas is of great importance, especially for women who wish to have children. The HOLA® laser therapy by biolitec® is a gentle and effective treatment alternative by means of laser, which can be performed on an outpatient basis and under local anesthesia. Myomas can be enucleated quickly and gently with MyoFiber® glass fibers in different designs. The laser energy avoids the contraction of the uterine muscles and can therefore be used without or under minimal local anesthesia. The extremely gentle procedure with continuous irrigation with saline solution ensures a quick return to normal activities.

In urology the minimally invasive laser treatment LIFE of biolitec® with its channel technique is particularly suitable for the treatment of benign prostatic hyperplasia in high-risk patients. Urologists at Harasanshin Hospital Fukuoka in Japan helped develop this special channel technique and operated on 26 patients who either suffer from diabetes and/or have to take anticoagulants. With the channel technique, surgery could be performed much faster than with conventional procedures – on average 1 hour – and a large cavity could be achieved without having to remove the tissue completely. Side effects such as swelling, dysuria or retention, which are particularly common in large glands, did not occur.

Already at the beginning of this year biolitec® presented its „Sharp tip“ laser fiber especially for microsurgical procedures. This needle-shaped fiber tip is the first laser fiber worldwide that can cut and coagulate without coupled or adapted separate endings. The surgeon can easily guide the glass fiber and thus in most cases completely replace the classic scalpel. This enables even safer handling compared to conventional laser systems. The „Sharp tip“ fiber is the first laser scalpel made of a homogeneous piece of glass fiber that can be used, for example, to perform slip-eye operations simply and precisely.

The biolitec® team presents at this year’s Medica in Dusseldorf at booth H46 in hall 10 not only the above mentioned innovations but also the complete range of the proven LEONARDO® laser family.

The LEONARDO® laser family includes the lasers of the LEONARDO® Dual series in 45 watt, 100 watt and 200 watt strengths, which are all characterized by the stepless use of the two wavelengths 980nm and 1470nm during treatment. These lasers are the most versatile medical lasers available on the market today. They are suitable for phlebology and proctology as well as minimally invasive surgery in urology, gynecology, ENT, orthopedics, thoracic surgery and pneumology, esthetic surgery and ophthalmology. The innovative LEONARDO® Mini completes the laser family. This device, which weighs just 900 grams, is available in a version with a wavelength of 1470 nm and as LEONARDO® Mini Dual with two wavelengths of 980 nm and 1470 nm. The small laser can also be used mobile in the established biolitec® treatment methods for venous diseases, haemorrhoids, fistulas, a broad spectrum of ENT diseases, in urology, gynecology and orthopedics.

About biolitec
biolitec® is one of the world’s leading medical technology companies in the field of laser applications and the only provider which possesses all the relevant core competences in the field of photodynamic therapy (PDT) – photosensitizers, lasers and fibre optic cables. Besides laser-supported treatment of cancers with the drug Foscan®, biolitec® researches and markets above all minimally invasive, gentle laser procedures.
ELVeS® Radial® (Endo Laser Vein System) is the world’s most-used laser system to treat venous insufficiency. The LEONARDO® diode laser from biolitec® is the first universally applicable medical laser which has a combination of two wavelengths, 980nm and 1470nm, and which can be used across disciplines. The innovative contact fibre XCAVATOR® in conjunction with the LEONARDO® DUAL 200 Watt laser allows in urology a gentle treatment of e.g. benign prostate enlargement (BPH). The light-weight LEONARDO® Mini laser weighing only 900 g was developed especially for mobile application on site. Gentle laser applications in the fields of proctology, ENT, gynecology, thorax surgery and pneumology are also part of biolitec®’s field of business. More information available at www.biolitec.com

Contact
biolitec
Joern Gleisner
Otto-Schott-Str. 15
07745 Jena
Phone: +49 (0) 3641 / 51953-36
Fax: +49 (0) 6172 / 27159-69
E-Mail: joern.gleisner@biolitec.com
Url: http://www.biolitec.com

Medicine Wellness Health

Maisense to Showcase Smart Cardio Monitoring Solution at MEDICA 2018

Maisense to Showcase Smart Cardio Monitoring Solution at MEDICA 2018

Smart Cardio Monitoring with Maisense Freescan

Hsinchu, Taiwan Nov 7th, 2018 – Maisense, an innovative startup, devoted to stroke prevention, announced its attendance at the MEDICA 2018, in Düsseldorf, Germany from November 12th to 15th. Besides showcasing its solution on Stand B26, Hall 11, the company will also present at the „Taiwan Biomedical Solution Spotlight“ in room 814, Hall 8B, as well as a presentation at MEDICA Connected Healthcare Forum.

Over 5,000 exhibitors from almost 70 countries are expected to attend MEDICA and digital medicine remains a leading topic this year. Maisense is honored to be part of this distinguished gathering to showcase their achievements in cardiovascular care.

Maisense is keeping pace with the current trend. Bach Chen, Vice President of business development, Maisense, will deliver an insightful presentation titled „A mobile device to take multiple cardiovascular parameters simultaneously“ at the MEDICA Connected Healthcare Forum on November 15th. The MEDICA Connected Healthcare Forum provides a platform for showcasing innovative Internet of Things solutions that are transforming the healthcare industry. „We are excited to share this telecardiology system which is to simplify the measurement procedure for patients,“ said Bach Chen.

Not only does Maisense improve the processes of measurement through the palm-sized „Freescan“ device, but it also enables patients to easily manage their own health by monitoring and analyzing their own vital signs using the intelligent „myFreescan“ App. Patients can observe many features on myFreescan, such as a trend view for historical blood pressure measurements, artery age, AFib/ arrhythmia screening, and ECG/pulse waveform viewing. If the patient has activated this feature, an instant doctor“s advice can be sent through the Patient Care System if further care is needed. Maisense is the world“s first company to provide an all-in-1 solution to screen the top 3 causes of stroke: arterial stiffness, hypertension, and atrial fibrillation in single device

How important the monitoring of these values is for early detection and which devices can be used for measurements explains Prof. Dr. med. Med. Thomas Wendt, who also mentions Maisense Freescan as an easy-to-use device, without the need of additional applying electrodes on the patient“s chest, in a recent broadcast of „Service: Gesundheit“ in ARD (minute 00:17 in the video, available in the ARD library).

The myFreescan APP has been selected as one of the 10 finalists in the 2018 MEDICA APP Competition. „This recognition as a top 10 finalists fuels our commitment to provide patients and doctors with a better way for chronic disease management and stroke prevention,“ said Benjamin Chiu, CEO, Maisense. The MEDICA APP Competition is not only awarding stand-alone-apps, but rather wellthought-out overall solution for the day-to-day use of patients, doctors and clinics. The top ten solutions will be presented at the MEDICA Connected Healthcare Forum, Hall 15C24 on Nov. 14 from 3pm.

Maisense is honored to also have been selected as one of the most innovative manufacturers and solution providers for the „Taiwan Biomedical Solution Spotlight“ in room 814, Hall 8B, on Nov. 14. Maisense will be on the stage to demonstrate the cardiovascular solution and seeking opportunity for further cooperations. The company is looking for both partners to grow its European channel as well as for Digital Health SI (System Integration) partners.

In addition to product demos for Freescan, myFreescan and the Patient Care System, the Maisense experts are available on Stand B26, Hall 11 to discuss atrial fibrillation detection and the latest results of clinical studies in Europe and Taiwan.

Freescan is now available in Germany at Mindtec( https://www.mindtecstore.com/Maisense-Freescan-Cardiovascular-Monitor) and ME Health CHECK( https://www.mehealthcheck.de/maisense-freescan-bestellen/16/freescan-ihr-persoenliches-blutdruckmessgeraet-zur-herz-kreislauf-kontrolle?c=16). Maisense is looking for distributors in European Union, Asia, and Middle East.

About Maisense:
Maisense is an innovative startup working in non-invasive medical cardiovascular monitoring for personal use, combined with artificial intelligence software for stroke prevention including AFib/arrhythmia/artery stiffness detection for professional physician use. Founded in 2012, Maisense was granted the award for „Best Investment Potential“ by Taiwan“s Ministry of Economic Affairs. Maisense“s Freescan is the world first cuffless blood pressure monitor measuring directly from wrist pulse and it has received EU CE medical certification. It has been honored with the 2015 National Innovation Award in Taiwan, as well as ranking second among the Top 10 Innovative Health Products at the Arab Health 2016 fair in Dubai. In 2017, it has received the „Taiwan top 10 coolest innovative startups award“ from the Ministry of Science and Tech in Taiwan. For more information, visit www.maisense.com

Company-Contact
Pressoffice Maisense
Wibke Sonderkamp
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.40
E-Mail: wibke@gcpr.net
Url: http://www.maisense.com/en/

Press
Pressoffice Maisense
Laura Lehmann
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.52
E-Mail: laura@gcpr.net
Url: https://www.gcpr.de/

Medicine Wellness Health

Made in Taiwan: improved medical outcomes – MEDICA 2018

The Taiwan External Trade Development Council – TAITRA – presents an elite group of 15 companies at this year’s MEDICA.

Made in Taiwan: improved medical outcomes - MEDICA 2018

Taiwan is a country founded on technology and the relentless drive for innovation. It benefits from the ambitions of its individual researchers, their institutes and companies and from the engagement and support from the Taiwan External Trade Development Council – TAITRA. At this year“s MEDICA, TAITRA presents an elite group of 15 companies – the recipients of TAITRA’s Taiwan Excellence awards – displaying technology to improve efficiency, process and, ultimately, outcomes to the world“s doctors, caregivers, and patients.

The world’s population is aging and becoming more connected. This fact is of utmost importance to Taiwan; its commercial sectors are focused on issues associated with a citizenry maturing in-step with the West. Rehabotics Medical Technology Corporation has just brought an exceptional aid to the market, MirrorHand, which enables robot-assisted rehabilitation of the hands after a stroke. Weighing only 750 grams, it is by far the lightest robotic rehabilitation device for the hand. The mirrored motion transferred from healthy to compromised hand and the programmable passive motion rehabilitation functions support neuromuscular regeneration.

Some unique technologies are just as beneficial at either end of life. The Opro9 Smart Diaper from Civicloud is an example. By offering a diaper with networked moisture monitoring, this technology is an excellent low-cost, multifunctional device. Whether in a NICs unit where renal function monitoring is a key aspect to positive outcomes, to an assisted living center where the care must remain efficient but responsive and flexible, this simple system can alert staff to needs of each patient and ensure an exceptional quality of care while offering valuable data-points into the EHR.

The ability for doctors to reach rapid, accurate conclusions is key to diagnosis and continued evaluation. Leltek Inc. offers this through a best-in-class cordless ultrasound subsystem. Of particular interest is their system’s bring-your-own-device compatibility, its ultra-light design at only 330 grams, and the exceptional battery life of three hours – overcoming the issues associated with previous cordless ultrasound solutions.

Another company featured through Taiwan Excellence, AmCad, leverages existing ultrasound diagnostic equipment to achieve the most cost-effective sleep apnea (OSA) diagnosis. As the understanding of the denigrating effects this condition plays in the general population becomes established, AmCad’s UO system delivers standardized ultrasound-head positioning and output data analysis to achieve an accurate diagnosis within 10 minutes on a fully awake patient, thereby eliminating the need for expensive overnight evaluation.

These Taiwan Excellence recipients and others organized by TAITRA will be presented during the MEDICA in Dusseldorf, Germany, from November 12th through the 15th in hall 17 Stand A61. All are interested in realizing opportunities for technological cooperation and business development with the global medical community. Hosts are on-hand and individual tours are available to meet your goals.

Founded in 1970 to help promote foreign trade, the Taiwan External Trade Development Council (TAITRA) is the foremost non-profit trade promotion organization in Taiwan. Jointly sponsored by the government, industry associations, and several commercial organizations, TAITRA assists Taiwan businesses and manufacturers with reinforcing their international competitiveness and in coping with the challenges they face in foreign markets.

TAITRA boasts a well-coordinated trade promotion and information network of over 1,300 trained specialists stationed throughout its Taipei headquarters, four local branch offices in Hsinchu, Taichung, Tainan and Kaohsiung, and 60 overseas branch offices worldwide. Together with its sister organizations, Taiwan Trade Center (TTC) and Taipei World Trade Center (TWTC), TAITRA has created a wealth of trade opportunities through effective promotion strategies.

Company-Contact
Taiwan External Trade Development Council
Frances Lin
Immermannstr. 33
40210 Dusseldorf
Phone: +49 (0)228 / 919 37 -66
E-Mail: taiwanexcellence@agentur-drilling.de
Url: https://www.taiwanexcellence2018.de/pk/

Press
DRILLING GmbH
Ben Giese
CelsiusStr. 43
53125 Bonn
Phone: +49 (0)228 / 919 37 -66
E-Mail: taiwanexcellence@agentur-drilling.de
Url: https://www.taiwanexcellence2018.de/pc/

Medicine Wellness Health

Uwe Diegel joins healthbank

Health database platform healthbank with new product manager – Diegel has been at the forefront of international changes in healthcare technology for the last 30 years

Uwe Diegel joins healthbank

Uwe Diegel

healthbank, the innovative platform for health data management in Switzerland, is happy to announce the arrival of Uwe Diegel in the role of Head Product Management product manager. Uwe Diegel was a concert pianist until the age of 26 and, following an accident that partially restricted movement in right arm, started a new career in medical diagnostics, quickly developing a particular interest in chronic diseases such as hypertension, asthma and diabetes. His intense scientific curiosity has led him not only to develop new technologies in these fields, but also to interest himself to field of medical manufacturing, industrial design and artificial intelligence.

Uwe is today considered to be a foremost expert in the field of blood pressure management, diabetes, asthma and in the manufacturing of medical diagnostics devices. In 2009, Uwe got interested in connected health as a means of providing better patient management and became involved in iHealth, the world leader in the field of connected health. Uwe served as CEO of iHealthLabs Europe until 2016. He left iHealth in 2016 to focus on health data management research.
Uwe Diegel has been at the forefront of international changes in healthcare technology for the last 30 years. His drive and passion for innovative technology have driven major changes in perception about healthcare. He has driven the manufacturing of medical devices to new horizons by forcing new practices in manufacturing and innovation. An internationally recognized expert in the management of cardiovascular disease and diabetes, he is continuously looking for better solutions to improve outcomes for patients. He has for the last few years spearheaded the dissemination and acceptance of connected health as a tool for providing better solutions for patients.
According to Uwe Diegel, „the creation of a new model of health and healthcare is the greatest single business opportunity of our lifetimes, and it will be accompanied by profound and lasting cultural change. Connection is everywhere and anything that can be connected will be connected. Connection is simply a natural evolution of technology. Every day, an average human being generates 500 megabytes of data, and now, most of this data is wasted. With healthbank, we expect to turn this data into something tremendously valuable financially, but more importantly tremendously valuable for medical research. Healthcare management is not the future of medicine, but its actual present. Tomorrow“s healthcare systems will consist of solutions, not for everyone, but indeed for every single one of us. And this is what we want to do with healthbank“.

About healthbank
healthbank is the world’s first citizen-owned, neutral and independent health data transaction platform that enables peo-ple to share their data in a secure and privacy compliant way with other partners. healthbank connects data sources of all kinds from the entire health sector and rewards participants to share their health data for research purposes. Based in Switzerland, healthbank stands for Swiss neutrality, trust and data protection and enables participating citizens, research-ers and organisations with large amounts of data to network with each other. Thus, the value of health and medical data can be optimally tapped on this independent, global health platform. healthbank promotes innovations in health care, from prevention to cure, at a more reasonable price and of better quality, for the benefit of individuals and society.
www.healthbank.coop

Company-Contact
healthbank
Pauline Geniets
Blegistrasse 17a
6340 Baar
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Press
healthbank
Roger Huber
Gartenstrasse 36
8002 Zürich
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Medicine Wellness Health

Maisense Presents AI-based Solution to Screen Atrial Fibrillation in Early Phase to Improve Stroke Prevention

Maisense Presents AI-based Solution to Screen Atrial Fibrillation in Early Phase to Improve Stroke Prevention

Freescan: the AI-based solution for stroke prevention (Source: © Maisense)

Hsinchu, Taiwan Oct 9th, 2018 – Maisense, an innovative startup, devotes itself to stroke prevention. The company now introduces an AI-based solution that can screen stroke through early detection of atrial fibrillation (AFib) which will also be presented at MEDICA 2018 November 12-15 in Düsseldorf, Germany at booth B26/Hall 11 and is a finalist for the MEDICA App COMPETITION.

Every four minutes, someone dies of stroke. Stroke is also a leading cause of long-term disability. Stroke is even called the „silent killer“ because it often come without any warning signs. However, up to 80% of stroke could be preventable by monitoring the major risk factors of stroke at an early stage.

13% of strokes are classified as hemorrhagic stroke. When the arteries of the brain weaken or break, allowing for blood to spread in the brain tissues, hemorrhagic strokes occur. They are most often caused by chronically hypertension. Up to 87% of strokes are classified as ischemic. An ischemic stroke occurs when a clot or a mass blocks a blood vessel, cutting off blood flow to a part of the brain. There are two main risk factors of ischemic strokes: arterial stiffness and atrial fibrillation (AFib).

A research, „Changes in arterial stiffness independently predict stroke in patients with essential hypertension,“ published in 2018 European Society of Cardiology (ESC), shows a demonstrated association and prediction between arterial stiffness and stroke for essential hypertension patients. The Framingham Heart Study (FHS) identified common factors and characteristics contributed to cardiovascular disease. Low-density lipoprotein (LDL), also called the „bad cholesterol“, is a notable enemy of arterial elasticity and fosters arterial stiffness. High LDL level raises the chances of a heart attack because it deposits in the walls of blood vessels that narrows the arteries or even clog. Other risk factors such as age, hypertension, smoking and diabetes are highly related to cardiovascular diseases.

It’s worth noting that patients with AFib have a five-fold increase in risk of stroke compared to those without. It affects 4.5 million people living in the European Union, and accounts for approximately one-third of hospitalizations for cardiac rhythm disturbances. The European Heart Rhythm Association (EHRA), who published the aforementioned numbers, released a classification system of AFib-related symptoms in 2014. EHRA also stressed the fatal consequence even if AFib symptoms are not noticeable to patient or they may not feel uncomfortable. „Since an AFib episode can come and go, there may be many patients undetected and therefore they didn“t receive timely treatment. That“s why we take AFib screening seriously as a key measurement for stroke prevention,“ said Benjamin Chiu, CEO of Maisense.

AFib is usually diagnosed on an ECG but if a patient“s symptoms don“t occur while he sees his doctor or if they are back to normal at this point of time, the doctor would not be able to give advice properly. As a result, Maisense presented the Freescan device and the myFreescan App, which deliver an all-in-1 solution, utilizing artificial intelligence (AI) for early AFib detection, arrhythmia (bradycardia and tachycardia) detection, pulse wave velocity, and blood pressure monitoring in a single device. Users adopting Maisense’s solution can assess their risk level of strokes anytime.

From the patient“s perspective, the solution makes it very easy to measure and record all these biomedical signals at any time. Patients can monitor their own health conditions and take action at an early stage. Through the web-based Patient Care System, doctor can also be informed immediately when abnormal incidents occur – if a patient activated this function under doctor-patient privilege. It also provides sufficient data for doctors to make assessment quickly. The option does not only help to avoid unnecessary healthcare spending and time investments but also improves the service efficiency.

As Apple announced its Watch Series 4, which can record ECG and has received FDA approval, it is believed that more and more people are noticing the importance of irregular heart rhythm detection. Maisense is the world“s first company to provide an all-in-1 solution to screen the top 3 causes of stroke: arterial stiffness, hypertension, and atrial fibrillation in one single device. Maisense“s Freescan has received EU CE medical certification and is now available in Germany. Maisense will also present the solution at the upcoming „MEDICA 2018“ trade fair on November 12-15 in Düsseldorf, Germany, in Hall 11/ booth B26. Freescan has been selected as one of the 10 finalists in the MEDICA App COMPETITION ( https://www.medica-tradefair.com/cgi-bin/md_medica/lib/pub/tt.cgi/MEDICA_App_COMPETITION.html?oid=46182&lang=2&ticket=g_u_e_s_t). The top ten solutions will be presented at the MEDICA Connected Healthcare Forum, Hall 15C24 on Nov. 14 from 3pm.

For more information on pricing and the availability of Freescan, please visit Mindtec: https://www.mindtecstore.com/Maisense-Freescan-Cardiovascular-Monitor
and ME Health CHECK: https://www.mehealthcheck.de/maisense-freescan-bestellen/16/freescan-ihr-persoenliches-blutdruckmessgeraet-zur-herz-kreislauf-kontrolle?c=16

About TITAN Commerce
TITAN Commerce“s wide product range includes state-of-the-art biotechnology, wearables and professional Sportswear technologies from various well-known biofeedback, neurofeedback and wearable manufacturers. The goal of TITAN Commerce is to provide end-customer with the most technically innovative products to help them to deal with their daily impact of external influences such as stress, exhaustion, concentration and attention deficits. For more information, please visit: www.titan-commerce.com

About appPeople
Founded in 2011, appPeople GmbH develops and distributes mobile applications and medical devices. The innovative products enable the regular collection of relevant health parameters, helping to better assess treatment outcomes and improve users‘ quality of life. The dynamically growing company works with partners in Europe and Asia and is one of the most successful and creative names in its field. For more information, please visit: www.mehealthcheck.de

About Maisense:
Maisense is an innovative startup working in non-invasive medical cardiovascular monitoring for personal use, combined with artificial intelligence software for stroke prevention including AFib/arrhythmia/artery stiffness detection for professional physician use. Founded in 2012, Maisense was granted the award for „Best Investment Potential“ by Taiwan“s Ministry of Economic Affairs. Maisense“s Freescan is the world first cuffless blood pressure monitor measuring directly from wrist pulse and it has received EU CE medical certification. It has been honored with the 2015 National Innovation Award in Taiwan, as well as ranking second among the Top 10 Innovative Health Products at the Arab Health 2016 fair in Dubai. In 2017, it has received the „Taiwan top 10 coolest innovative startups award“ from the Ministry of Science and Tech in Taiwan. For more information, visit www.maisense.com

About GLORIA-Semicon:
„GLORIA-Semicon“ – (Global Research & Industry Alliance Semiconductor) of Taiwan Ministry of Science & Technology is a platform that promotes high value-added and cross-field innovative products and services, and also dedicates in exploring and expanding the opportunities for members“ pioneering design to connect with Taiwan industry and academy resources. For more information, please visit http://riact.nctu.edu.tw/

GLORIA-Semicon is now coordinating a special interest group (SIG) for biomedical devices providers. Connections in between medical doctors, clinical trials as well as interdisciplinary researches are being sponsored by Taiwan government. We welcome international partners and jointly explore new businesses and channels especially in Chinese communities.

Dedication of GLORIA-Semicon:
– Allying global entrepreneurs with Taiwan semiconductor eco-system
– Providing one-stop services
– Facilitating global entrepreneurs in Taiwan to connect with local resources
– Collaborating with excellent academic groups in technical development

Company-Contact
Pressoffice Maisense
Wibke Sonderkamp
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.40
E-Mail: wibke@gcpr.net
Url: http://www.maisense.com/en/

Press
Pressoffice Maisense
Laura Lehmann
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.52
E-Mail: laura@gcpr.net
Url: https://www.gcpr.de/

Medicine Wellness Health

Capnography Equipment Market Size 366.5 Million by 2023 to Reach 4.3% CAGR

The global capnography equipment market to dominate by APAC while the overall market is to reach 4.3% CAGR to hit 366.5 million during 2016-2023 driven by accessories segment.

Capnography Equipment Market Size 366.5 Million by 2023 to Reach 4.3% CAGR

Watchers of Markets BV Logo

The global capnography equipment market is projected to reach USD 366.5 million by 2023 from USD 297.1 million in 2018, at a CAGR of 4.3%. Factors such as the development of portable/point-of-care capnography devices, clinical benefits of capnography equipment over pulse oximetry, increasing number of surgeries, and the evolving guidelines related to the clinical use of capnography are expected to drive the demand for capnography equipment in the coming years. However, the limited awareness about capnography and the shortage of skilled professionals to operate capnometers are the key challenges in this market.

Request a Sample PDF Copy of This Research Report: https://bit.ly/2NJOs5T

Based on product, the market is segmented into capnometers and accessories. The accessories segment is expected to account for the largest share of the capnography equipment market in 2018. The increasing adoption of capnography equipment during surgical procedures and post-operative monitoring, recommendations by various associations worldwide for the use of capnography equipment during patient monitoring for anesthesia (to enhance patient safety), and the growing number of complex and critical surgical procedures worldwide are the major factors that are expected to drive the growth of the capnography accessories market.

Based on end user, the market is segmented into hospitals and ambulatory surgery centers & home care. In 2018, the hospitals segment is expected to account for a larger share of this market. Factors such as the evolving guidelines related to the use of capnography and the rising incidence of chronic disorders are expected to drive the demand for capnography equipment in hospitals in the coming years.

The capnography equipment market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. The Asia Pacific is estimated to be the fastest-growing regional segment in the capnography equipment market majorly due to the presence of a large target patient population in the region, coupled with the increasing adoption of patient monitoring devices, including capnography equipment, due to the decreasing product costs as a result of local manufacturing and the strengthening of the distribution networks of prominent manufacturers. The growing medical tourism in several APAC countries is also expected to support the growth of this regional market during the forecast period.

Some of the major players operating in the capnography equipment market are NIHON KOHDEN (Japan), Philips (Netherlands), Medtronic (Ireland), Smiths Group (UK), Masimo Corporation (US), Drägerwerk AG & Co. KGaA (Germany), Hill-Rom Holdings (US), Nonin Medical (US), Infinium Medical (US), Criticare Technologies (US), SCHILLER (Switzerland), Zoe Medical (US), Edan Instruments (China), and Burtons Medical Equipment (UK).

Read More for Table of Content / Contact Us for the Corporate Discount: https://bit.ly/2IlT2ky

In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, innovation and technology directors, and executives from various key organizations operating in the market.

By Company Type: Tier I – 45%; Tier II – 34%; and Tier III – 21%

By Designation: C-level – 14%; Director-level – 10%; and Others – 76%

By Region: North America – 40%; Europe – 32%; APAC – 20%; and RoW – 8%

Related Report:

Structural Heart Devices Market by Product (Heart Valve Devices (Transcatheter and Surgical), Occluders and Delivery Systems, Annuloplasty Rings, and Accessories), Procedure (Replacement and Repair) – Global Forecast to 2023

The global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2%. The rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases are the major factors driving the growth of the structural heart devices market.

The structural heart devices market in the Asia Pacific is projected to register the highest CAGR during the forecast period while the replacement procedures segment is expected to register the highest CAGR during the forecast period.

The major players operating in the structural heart devices market are Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK).

Read More: https://bit.ly/2xFMc5y

About Us:

We are a leading market research store (headquartered in The Hague, Netherlands) bringing to you market research insights, analysis and data from many market research publishers around the globe.

Our experienced market research consultants understand a client“s research requirements in precise manner and get as many proposals around the globe as possible on the table suiting your budget and mapping your research goals.

Our only motivation is to provide clients with precise insights into their respective niche markets and offering them the most comprehensive portfolio of business information products.

Contact
Watchers of Markets BV
Vinay Kudale
Henriëtte van der Meydreef 144
2492 JG Den Haag
Phone: +31- 85 888 111 6
E-Mail: sales@watchersofmarkets.com
Url: https://watchersofmarkets.com/

Medicine Wellness Health

Maisense Presented Telecardiology System That Can Measure Blood Pressure and Record ECG Simultaneously at ESC Munich

Maisense Presented Telecardiology System That Can Measure Blood Pressure and Record ECG Simultaneously at ESC Munich

Bach Chen, Vice President of business development, Maisense (Source: © Maisense)

Hsinchu, Taiwan Aug 29th, 2018 – Maisense, an innovative startup, devotes itself to stroke prevention, today announced the telecardiology system using a portable device „Freescan“ that can measure blood pressure and record ECG simultaneously.

„For most telecardiology systems on the market, they either provide only ECG, or provide both blood pressure and ECG but retrieve them from two independent devices. The more devices there are, the less likely for patients to use all of them regularly.“ said Bach Chen, Vice President of business development, Maisense.

The purpose of Maisense“s telecardiology system is to simplify the measurement procedure for patients. Through the combination of three elements: the Freescan device, the myFreescan App, and the Patient Care web platform, patients can measure blood pressure and ECG with a single device. In addition, doctors are able to monitor patients“ health condition easily through the web-based Patient Care System. Maisense Freescan in combination with the myFreescan App delivers a combined all-in-1 solution utilizing artificial intelligence (AI) for early atrial fibrillation detection (AFib), arrhythmia (bradycardia and tachycardia) detection, pulse wave velocity, and blood pressure monitoring in a single device.

According to World Health Organization (WHO)“s report in May 2018, stroke incidents are globally the second most common cause of death after ischaemic heart disease. Of the 56.9 million deaths worldwide in 2016, almost 6 million died persons died of strokes, this is about 10% of all the accounted deaths. However, up to 80% of strokes may be preventable by monitoring the major risk factors: arterial stiffness, atrial fibrillation (AFib), and hypertension.

The adoption of Maisense“s telecardiology system will enable every user of the solution to assess their risk level of strokes anytime. Therefore then they can take preventive actions to minimize the risk.

Maisense held a session to elaborate telecardiology system at the ESC (European Society of Cardiology) congress in Munich on August 28th.
„I believe that solid researches lead to excellent innovation. Therefore, we continue to push the boundaries on digital health support, and on top of that, we value each opportunity to present our system at conferences or academia“, said Benjamin Chiu, CEO, Maisense.

Maisense is also growing its channel and is actively looking for distributors in the European Union. In Germany, Maisense is excited to have formed a partnership with the well renowned TITAN Commerce and appPeople. TITAN Commerce is a leading distributor for Bio-/Neurofeedback, sportswear technology and wearables based in Germany. appPeople provides worldwide progressive impulses in the field of telemedicine. Freescan is also available in Germany at Mindtec and ME Health CHECK.

Maisense is proud to be a member of the Global Research & Industry Alliance (GLORIA-Semicon) which focuses on future-oriented technology and builds a cooperation platform between universities and the industry. The organization stimulates innovation and introduces Taiwan startup companies to the global market.

About TITAN Commerce
TITAN Commerce“s wide product range includes state-of-the-art biotechnology, wearables and professional Sportswear technologies from various well-known biofeedback, neurofeedback and wearable manufacturers. The goal of TITAN Commerce is to provide end-customer with the most technically innovative products to help them to deal with their daily impact of external influences such as stress, exhaustion, concentration and attention deficits. For more information, please visit: www.titan-commerce.com

About appPeople
Founded in 2011, appPeople GmbH develops and distributes mobile applications and medical devices. The innovative products enable the regular collection of relevant health parameters, helping to better assess treatment outcomes and improve users‘ quality of life. The dynamically growing company works with partners in Europe and Asia and is one of the most successful and creative names in its field. For more information, please visit: www.mehealthcheck.de

About Maisense:
Maisense is an innovative startup working in non-invasive medical cardiovascular monitoring for personal use, combined with artificial intelligence software for stroke prevention including AFib/arrhythmia/artery stiffness detection for professional physician use. Founded in 2012, Maisense was granted the award for „Best Investment Potential“ by Taiwan“s Ministry of Economic Affairs. Maisense“s Freescan is the world first cuffless blood pressure monitor measuring directly from wrist pulse and it has received EU CE medical certification. It has been honored with the 2015 National Innovation Award in Taiwan, as well as ranking second among the Top 10 Innovative Health Products at the Arab Health 2016 fair in Dubai. In 2017, it has received the „Taiwan top 10 coolest innovative startups award“ from the Ministry of Science and Tech in Taiwan. For more information, visit www.maisense.com

About GLORIA-Semicon:
„GLORIA-Semicon“ – (Global Research & Industry Alliance Semiconductor) of Taiwan Ministry of Science & Technology is a platform that promotes high value-added and cross-field innovative products and services, and also dedicates in exploring and expanding the opportunities for members“ pioneering design to connect with Taiwan industry and academy resources. For more information, please visit http://riact.nctu.edu.tw/

GLORIA-Semicon is now coordinating a special interest group (SIG) for biomedical devices providers. Connections in between medical doctors, clinical trials as well as interdisciplinary researches are being sponsored by Taiwan government. We welcome international partners and jointly explore new businesses and channels especially in Chinese communities.

Dedication of GLORIA-Semicon:
– Allying global entrepreneurs with Taiwan semiconductor eco-system
– Providing one-stop services
– Facilitating global entrepreneurs in Taiwan to connect with local resources
– Collaborating with excellent academic groups in technical development

Company-Contact
Pressoffice Maisense
Wibke Sonderkamp
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.40
E-Mail: wibke@gcpr.net
Url: http://www.maisense.com/en/

Press
Pressoffice Maisense
Laura Lehmann
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.52
E-Mail: laura@gcpr.net
Url: https://www.gcpr.de/

Medicine Wellness Health

One Swiss model for the world – healthbank expands into Germany

healthbank Deutschland GmbH founded in Berlin – Karsten Stampa becomes CEO – Philosophy and values of the cooperative are transported

One Swiss model for the world - healthbank expands into Germany

Karsten Stampa

healthbank cooperative is expanding and has founded the subsidiary healthbank Deutschland GmbH in Berlin. CEO of the new company is Karsten Stampa, who contin-ues to act as COO/CFO of the parent company healthbank in Baar. „We are convinced that the model of a new and independent health data platform is not only a model for Switzerland, but for the whole world,“ explains Stampa.

The Swiss health data platform „healthbank“ revolutionizes the way personal health data is stored, used, exchanged and passed on for fair rewards. To this end, healthbank operates the world’s most advanced health data platform, which allows users to securely store health data and share it with doctors, hospitals and research institutions by means of authorization.

For Karsten Stampa, the move to Berlin is a logical step in health-bank’s expansion strategy. „We are convinced that our model of a neutral and independent health data platform is not only a model for Switzerland but will prevail all over the world.

The goal of healthbank in the near future is to offer the possibility of being able to use personal health data everywhere and at any time: „So not only at home, but also for example on vacation in the Serengeti or when one is on the road professionally“, explains Stampa. The data would be urgently needed, especially at remote locations in the event of a medical emergency, would help to understand people’s medical history quickly and easily and thus improve the quality of care, no matter where in the world it takes place“.

In terms of internationalization, the branch in Germany is the logical step for healthbank, explains Stampa. „The reasons are clear. In Germany, the domestic market with around 80 million inhabit-ants is of course very interesting. Much more exciting, however, is the fact that many international healthcare providers are based there alongside highly exciting start-ups with excellent, innovative approaches in the field of digital health. For example, we have entered into a cooperation with Thryve, a company that develops and sells software as a service in the field of mobile health applications,“ adds Stampa. In addition to the development of the national telematics structure or the development of the electronic health card, Stampa explains that many other developments can currently be observed in Germany. The first frontrunner projects of German insurers such as the Techniker Krankenkasse, the patient file of the AOK Nord-Ost or the health app Vivy were observed. „We are convinced that healthbank, as a bridge builder between the partially isolated ap-proaches, can make a major contribution to the control of health data among users in Germany.

This expansion will later be extended to other countries around the world. „This will enable us to export our future model. The healthbank cooperative is located in Switzerland and enables users to share their data with other partners in a secure and data protection-compliant manner. healthbank combines data sources of all kinds from the entire health sector and rewards participants to share their health data for research purposes. For various reasons (including legislation), local operating companies will also have to be operated in the respective countries. „This will enable us to transport the philosophy and values of the Swiss cooperative to these countries and allow the healthbank ecosystem to grow rapidly worldwide,“ explains Stampa.
healthbank in Germany will soon start as a sales and operations company where customer relation-ships with German health service providers are to be established and project partners found. The core will be the announcement of the healthbank idea in Germany and the establishment of fur-ther customer relationships. „Through our cooperation with a globally active German management consultancy, we ensure a high degree of visibility in Germany“.

Stampa sees the implementation of the healthbank expansion strategy as one of his core tasks. „I have many discussions with potential customers and appearances at events,“ he explains. At the same time, the marketing strategy will be developed and implemented. „The search for investors and securing financing is always one of the most important tasks in such a project and is at the top of his list, explains the former management consultant in the areas of strategy and regulation. Stampa has therefore also planned a first funding round for the coming months in order to be able to build up the Marketing and Business Development department. „It may also be necessary to operate your own data platform in Germany so that an IT department can be added,“ explains Stampa.

About healthbank
healthbank is the world’s first citizen-owned, neutral and independent health data transaction platform that enables people to share their data in a secure and privacy compliant way with other partners. healthbank connects data sources of all kinds from the entire health sector and rewards participants to share their health data for research purposes. Based in Switzerland, healthbank stands for Swiss neutrality, trust and data protection and enables participating citizens, researchers and organizations with large amounts of data to network with each other. This enables the value of health and medical data to be optimally exploited on this independent, global health platform. healthbank promotes innovations in the health care system, from prevention to cure, at a more reasonable price and of better quality – for the benefit of individuals and society. www.healthbank.coop

healthbank ist die weltweit erste bürgereigene, neutrale und unabhängige Gesundheitsdaten-Transaktionsplattform, die es Menschen ermöglicht ihre Daten auf sichere und datenschutzkonforme Art und Weise mit anderen Partnern zu teilen. healthbank verbindet Datenquellen aller Art aus dem gesamten Gesundheitsbereich und belohnt Teilnehmer, ihre Gesundheitsdaten für Forschungszwecke zu teilen. Mit Sitz in der Schweiz steht healthbank für schweizerische Neutralität, Vertrauen und Datenschutz und ermöglicht es den teilnehmenden Bürgern, Forschern und Organisationen mit grossen Datenmengen sich miteinander zu vernetzen. Damit kann der Wert von Gesundheits- und medizinischen Daten auf dieser unabhängigen, globalen Gesundheitsplattform optimal erschlossen werden. healthbank fördert Innovationen im Gesundheitswesen, von der Prävention bis zur Heilung, zu einem angemesseneren Preis und besserer Qualität – für das Wohl des Einzelnen und der Gesellschaft.
www.healthbank.coop

Company-Contact
healthbank
Pauline Geniets
Blegistrasse 17a
6340 Baar
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Press
healthbank
Roger Huber
Gartenstrasse 36
8002 Zürich
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop